Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001171843-17-006832

Options or other derivatives

  • Chief Executive Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Daly Richard J Chief Executive Officer 2017-11-07 Grant or award · Common Stock Purchase Option +100,000 100,000 D: show line 1 in the form
Loading xslF345X03/formfour.xml…